Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia



Status:Completed
Conditions:Pneumonia
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 65
Updated:4/2/2016
Start Date:December 2005
End Date:July 2007
Contact:Medical Director
Email:clinical@enanta.com

Use our guide to learn which trials are right for you!

A Randomized, Double-Blinded, Parallel Group, Multicenter Study of EDP-420 Versus Telithromycin for the Treatment of Community Acquired Pneumonia

This study will compare the efficacy, safety and tolerability of EDP-420 versus another oral
antibiotic in the treatment of community acquired pneumonia


Inclusion Criteria:

- Recent respiratory illness with signs and symptoms and chest X-ray consistent with
the diagnosis of community-acquired pneumonia.

- Suitable candidate for oral antibiotic therapy and able to swallow large capsules
intact

- If female, must be non-lactating and at no risk for pregnancy

Exclusion Criteria:

- Other infections

- Other pulmonary diseases requirement multiple antibacterial medications or long
duration of therapy

- History of hypersensitivity, allergic or adverse reactions to macrolide, ketolide,
azalide or streptogramins

- Evidence of uncontrolled clinically significant disease, malignancy, or other
abnormality

- Requirement of parenteral antimicrobial therapy for treatment of pneumonia

- Currently receiving or likely to receive any known inhibitors or inducers of
cytochrome P450 mediated drug metabolism

- Immunocompromised subjects
We found this trial at
1
site
Watertown, Massachusetts 02472
?
mi
from
Watertown, MA
Click here to add this to my saved trials